Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze BIS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BIS investment potential.

What is BIS stock price today?

Get real-time BIS stock price, historical data, and price charts on Financhill. Track BIS performance with our advanced analysis tools.

Is BIS a good investment?

Evaluate BIS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BIS stock?

To buy BIS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BIS?

View detailed market capitalization data and company valuation metrics for BIS on our comprehensive analysis page.

What is the P/E ratio of BIS?

Use our fundamental analysis tools to view BIS P/E ratio and compare valuation metrics with industry peers.

What are BIS earnings?

View BIS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

ProShares UltraShort Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

BIS
ProShares UltraShort Nasdaq Biotechnology

Last Price:

$9.46

Seasonality Move:

-7.57%

7 Day Trial

ALL ACCESS PASS

$ 7

ProShares UltraShort Nasdaq Biotechnology Stock Forecast

Over the next 52 weeks, ProShares UltraShort Nasdaq Biotechnology has on average historically fallen by 29.8% based on the past 15 years of stock performance.
ProShares UltraShort Nasdaq Biotechnology has fallen lower in 13 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 86.67%
Is ProShares UltraShort Nasdaq Biotechnology Stock Undervalued?

The current ProShares UltraShort Nasdaq Biotechnology [BIS] share price is $9.46. The Score for BIS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
BIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotechnology Stock Go Up Next Year?

Over the next 52 weeks, ProShares UltraShort Nasdaq Biotechnology has on average historically fallen by 29.8% based on the past 15 years of stock performance.

ProShares UltraShort Nasdaq Biotechnology Stock Rating

Sell

ProShares UltraShort Nasdaq Biotechnology (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotechnology overpriced?

ProShares UltraShort Nasdaq Biotechnology has fallen lower in 13 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 86.67%

ProShares UltraShort Nasdaq Biotechnology Stock Price History

Is BIS stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Industry:

Sector:

Type:

etf

Website:

52-Week Data

52-Week High:

25.87

52-Week Low:

9.17

Prediction Charts

Market Cap:

Price in USD:

9.46

Volume:

12.7K

Beta:

-1.62

Technical Analysis

SMA50:

10.48

SMA100:

12.27

SMA200:

15.22

52-Wk Change:

-48.95%

Stock Predictions

Is ProShares UltraShort Nasdaq Biotechnology stock public?

Yes, ProShares UltraShort Nasdaq Biotechnology is a publicly traded company.
What is the ProShares UltraShort Nasdaq Biotechnology stock quote today?

The ProShares UltraShort Nasdaq Biotechnology stock price is 9.46 USD today.
How to buy ProShares UltraShort Nasdaq Biotechnology stock online?

You can buy ProShares UltraShort Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-2	9.61	9.74	9.75	9.55
Dec-3	9.62	9.36	9.62	9.35
Dec-4	9.42	9.38	9.42	9.31
Dec-5	9.28	9.46	9.50	9.28
Dec-8	9.34	9.53	9.53	9.34
Dec-9	9.46	9.85	9.86	9.46
Dec-10	9.76	9.65	9.77	9.64
Dec-11	9.58	9.50	9.58	9.47
Dec-12	9.40	9.55	9.62	9.40
Dec-15	9.50	9.55	9.65	9.46
Dec-16	9.63	9.65	9.78	9.61
Dec-17	9.60	9.79	9.80	9.57
Dec-18	9.74	9.93	9.98	9.74
Dec-19	9.45	9.46	9.48	9.39

ProShares UltraShort Nasdaq Biotechnology Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotechnology Forecast Revenue Growth